PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3131115-9	1988	Furthermore, treatment with 4-OHA caused a reduction in uterine estrogen receptor and progesterone receptor levels.	formestane	28-33	progesterone receptor	Rattus norvegicus	86-107	
7857875-1	1995	In previous studies, we observed that aromatase inhibitor 4-hydroxy-androstenedione (4-OHA) treatment significantly decreased estrogen (ER) and progesterone receptor (PR) concentrations in the uterus of ovariectomized (OVX) rats.	formestane	58-83	progesterone receptor	Rattus norvegicus	144-165	
7857875-1	1995	In previous studies, we observed that aromatase inhibitor 4-hydroxy-androstenedione (4-OHA) treatment significantly decreased estrogen (ER) and progesterone receptor (PR) concentrations in the uterus of ovariectomized (OVX) rats.	formestane	58-83	progesterone receptor	Rattus norvegicus	167-169	
7857875-1	1995	In previous studies, we observed that aromatase inhibitor 4-hydroxy-androstenedione (4-OHA) treatment significantly decreased estrogen (ER) and progesterone receptor (PR) concentrations in the uterus of ovariectomized (OVX) rats.	formestane	85-90	progesterone receptor	Rattus norvegicus	144-165	
7857875-1	1995	In previous studies, we observed that aromatase inhibitor 4-hydroxy-androstenedione (4-OHA) treatment significantly decreased estrogen (ER) and progesterone receptor (PR) concentrations in the uterus of ovariectomized (OVX) rats.	formestane	85-90	progesterone receptor	Rattus norvegicus	167-169	
7857875-3	1995	After 2 weeks of 4-OHA treatment both ER and PR were reduced in mammary tumors, as well as in uteri of intact animals (P < 0.05).	formestane	17-22	progesterone receptor	Rattus norvegicus	45-47	
7857875-10	1995	Treatment with 4-OHA reduced mRNA levels of ER and PR in uterus and tumors in intact and OVX animals.	formestane	15-20	progesterone receptor	Rattus norvegicus	51-53	
7857875-11	1995	Levels of tumor mRNA of both ER and PR were inhibited by 4-OHA treatment in estradiol treated OVX rats.	formestane	57-62	progesterone receptor	Rattus norvegicus	36-38	
7857875-12	1995	Thus, 4-OHA appears to inhibit ER and PR concentrations in mammary tumors of the rat by reducing transcription.	formestane	6-11	progesterone receptor	Rattus norvegicus	38-40